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Polyunsaturatedfattyacids(PUFAs)haveanti-inﬂammatoryeﬀectsatlowconcentrations;howeverincreaseddietaryconsumption
may conversely increase susceptibility to oxidation by free radicals. The objective of this study was to determine the eﬀects of
PUFAs on selective oxidative injury and inﬂammatory biomarkers in canine urine and serum. Dogs (n = 54) consumed a
diet supplemented with 0.5% conjugated linoleic acid/dry matter, 1.0% conjugated linoleic acid/dry matter, or 200mg/kg
docosahexaenoic acid/eicosapentaenoic acid for 21 days. All dogs exhibited signiﬁcantly increased plasma PUFA concentrations.
All dogs had signiﬁcant elevations in urinary F2a isoprostane concentration, though dogs consuming a diet containing 1.0%
conjugated linoleic acid/dry matter had the highest increase (P = .0052). Reduced glutathione concentrations within erythrocytes
decreased signiﬁcantly in all three dietary treatment groups (P = .0108). Treatment with diets containing 1.0% conjugated linoleic
acid/dry matter resulted in the greatest increase in oxidant injury. Caution should be exercised when supplementing PUFAs as
some types may increase oxidation.
1.Introduction
PUFAs are known to exert protective cellular eﬀects ag-
ainst injury, though the exact mechanism of protection
is unknown [1]. PUFAs are typically consumed in low
quantities. Studies evaluating PUFA dietary supplementa-
tion have had conﬂicting results [2]. Supplementation in
excess of normal dietary levels can result in a paradoxical
increase in susceptibility to free radical oxidant injury,
resulting from a combination of both relative increase
in PUFA concentration and relative decrease in anti-
oxidant content [2]. Reactive oxygen species react with
the double bond of these unsaturated lipids resulting in
lipid peroxidation, and increased risk of oxidative stress
[3].
The objective of this study was to determine the eﬀects of
21 days of PUFA dietary supplementation on plasma PUFA
levelsandselectoxidativeinjuryandinﬂammatorybiomark-
ers in urine and serum in healthy dogs. We hypothesized that
PUFA supplementation would augment plasma PUFA levels
and that augmentation may alter the REDOX status of these
healthy dogs.
2.MaterialsandMethods
The Institutional Animal Care and Use Committee approved
all procedures prior to conducting this research. Healthy
dogs were recruited from the students of the Colorado
State University College of Veterinary Medicine. Health
was assessed by physical examination, complete blood
count, serum biochemical panel, and routine urinalysis.
Signalment and weight were recorded. Once enrolled, dogs
underwent additional blood and urine testing to evaluate
baseline PUFA concentration and markers of oxidant injury
and inﬂammation. Dogs were randomly assigned to one
of three polyunsaturated fatty acid treatment groups in
which they consumed a diet supplemented with a capsule
containing 0.5% and 1.0% conjugated linoleic acid/dry
matter(Conjugated linoleic acid, Experimental and Applied
Science, Golden, CO.; Composition veriﬁed by Integrated
Biomolecule Corporation, Tucson, AZ.), or 200mg/kg body
weight docosahexaenoic acid/eicosapentaenoic acid (Omega
Pet, NBF-LANES srl, Milano, Italy.) for 21 days. In addition
to PUFA supplementation, dogs were fed their usual diets by
the owners with no changes in composition or quantity.2 Veterinary Medicine International
Table 1: Summary of eﬀect of PUFA dietary supplementation on PUFA levels and indices of oxidant injury and inﬂammation. Results
reported as mean and standard deviation. The symbol ∗ denotes signiﬁcant change between Day 0 and Day 21 measurements and
superscript letters indicate signiﬁcant diﬀerences between treatment groups. CLA Conjugated linoleic acid DHA docosahexaenoic acid EPA
eicosapentaenoic acid iPF2α-III urine 8-epi-prostaglandin F2α CRP C reactive protein.
Diet Treatment 0.5% CLA 1.0% CLA DHA/EPA
Timepoint DAY 0 DAY 21 DAY 0 DAY 21 DAY 0 DAY 21
CLA (18:2 c9,
t11)mg/dL
2.39 ±3.12 .49 ±1.6
∗ 3.01 ±3.03 .34 ± 2.6
∗ 1.70 ±2.11 .83 ±2.6
∗
CLA (18:2, t10,
c12)mg/dL
1.61 ±3.62 .65 ±2.0
∗ 2.25 ±3.54 .16 ± 4.0
∗ 0.92 ±1.61 .01 ±1.4
∗
DHA (C22:6n-3)mg/dL 7.34 ±3.69 .88 ±8.6
∗ 10.10 ±8.31 2 .74 ±9.6
∗ 11.81 ±9.81 9 .61 ±8.8
∗
EPA (C20:5n-3)mg/dL 2.31 ±1.52 .61 ±1.7
∗ 2.28 ±1.02 .90 ± 2.1
∗ 3.09 ±2.69 .44 ±5.6
∗
GSHμM/L 881.9 ±240.3 747.5 ±339.1
∗ 1045.4 ±429.3 617.0 ±418.3
∗ 814.9 ±277.1 836.0 ±225.1
∗
GSSGμM/L 46.3 ±51.64 0 .0 ±61.75 0 .5 ±44.52 3 .2 ±24.03 5 .4 ±24.24 0 .3 ±29.0
GSH:GSSG 52.6 ±75.17 7 .2 ±100.55 2 .1 ±60.94 5 .8 ±54.05 2 .0 ±80.35 8 .6 ±85.1
iPF2α-III
pg/mg creatinine
901.6 ±376.7 1169.6 ±484.3
∗a 1144.4 ±484.6 1673.8 ± 815.5
∗b 819.4 ±412.7 995.0 ±440.4
∗c
CRPmg/dL 0.51 ±0.07 0.51 ±0.77 0.49 ±0.03 0.52 ±0.08 0.51 ±0.07 0.49 ±0.03
aConjugated linoleic acid, Experimental and Applied Science, Golden, CO.
bConjugated linoleic acid purity and composition veriﬁed by Integrated Biomolecule Corporation, Tucson, AZ.
cOmega Pet, NBF-LANES srl, Milano, Italy.
At 0 and 21 days, blood and urine were evaluated for
PUFA concentration and markers of oxidant injury and
inﬂammation. Twenty-four mLs of blood was collected by
jugular venipuncture into collection tubes containing EDTA,
scavenger, or no additive. Whole blood samples in EDTA
were centrifuged at 2000g for 15 minutes. Plasma was then
decanted and frozen at −70
◦C until analysis. Plasma fatty
acids were measured by gas chromatography [4] (HP Gas
Chromatograph, Model 5980 series II, San Fernando, CA.).
Speciﬁc analytes included CLA (18:2 c9, t11 and 18:2,
t10, c12), DHA (C22:6n-3), and EPA (C20:5n-3). Small
aliquots of whole blood were placed into cryovials(Nalgene
Cryoware,NalgeCompany,Rochester,NY.)containingeither
no additive or 10% 1-methyl-2-vinylpyridinium triﬂuo-
romethanesulfonate scavenger for subsequent erythrocyte
reduced and oxidized glutathione (GSH:GSSG) analysis.
These samples were immediately ﬂash-frozen in liquid
nitrogen and stored at −70
◦C. Erythrocyte GSH:GSSG con-
centrationwasperformedusingacommerciallyavailabletest
kit (GSH/GSSG-412 Assay System, Oxis Research, Portland
OR). The remaining whole blood samples without additive
were allowed to clot and then centrifuged at 2000g for 15
minutes. Serum was then decanted and frozen at −70
◦C
untilanalysis.SerumC-reactiveprotein(CRP)wasmeasured
by spectrophotometry [5]. Urine was collected by voluntary
void or cystocentesis and stored at −70
◦C. Urine 8-epi-
prostaglandin F2α (iPF2α-III) by commercial ELISA. ( 8-
isoprostane ELISA, Genox Corporation, Baltimore, MD.).
3.StatisticalMethods
AmodiﬁedKolmogorov-Smirnovtestwasusedtoassessnor-
malityofdatadistribution.Continuousdatawerereportedas
mean and standard deviation. Bartlett’s test of homogeneity
was used to assess equality of variances for analysis of
variance (ANOVA). An ANOVA for treatment eﬀects, with
repeated measures for time eﬀects, followed by Fisher’s least
signiﬁcant diﬀerence test, was used to identify individual
group/time diﬀerences. Associations between continuous
variables were assessed by linear regression analysis. Fisher’s
“r to z” test was used to evaluate coeﬃcients. Results were
considered signiﬁcant at P<. 05.
4. Results
All dogs were judged to be healthy based on normal physical
examination, complete blood count, serum biochemical
panel, and routine urinalysis prior to inclusion. Mean age
o fd o g sw a s6y e a r sa n dr a n g e df r o m1t o1 0y e a r s .M e a n
weight of dogs was 25.5kg (SD:9.54kg). Twenty-nine males
and 25 females were included: ten males and 9 females
in the 0.5% conjugated linoleic acid/dry matter group, 9
males and 8 females in the 1.0% conjugated linoleic acid/dry
matter group, and 10 males and 8 females in the 200mg/kg
docosahexaenoic acid/eicosapentaenoic acid group. Dogs
did not receive any anti-inﬂammatory drugs or nutrient
supplements during the study period.
Continuous data are summarized in Table 1. Plasma
PUFA concentrations increased signiﬁcantly following sup-
plementation in all treatment groups. No linear associations
were detected between elevation in plasma PUFA con-
centration and markers of oxidative damage. Pretreatment
erythrocyte GSH concentrations were signiﬁcantly higher
than GSH posttreatment concentrations in all groups (P =
.0108), but no signiﬁcant individual treatment eﬀects were
detected. No change was seen in GSH:GSSG ratios. There
were no signiﬁcant changes in CRP concentrations with
respect to treatment or time eﬀects (P = .6102)Veterinary Medicine International 3
Urinary isoprostanes (iPF2α-III) were elevated in dogs
consuming 1.0% conjugated linoleic acid/dry matter fol-
lowing 21 days of treatment (P = .0102). In addition,
post-treatment levels of iPF2α-III were signiﬁcantly higher
in this group than both the 0.5% conjugated linoleic
acid/drymatter(P = .0052)and200mg/kgdocosahexaenoic
acid/eicosapentaenoic acid (P = .004) treatment groups.
5. Discussion
In this study, PUFA dietary supplementation in healthy dogs
over a 21-day period resulted in increased measured plasma
fatty acid concentrations. In addition, we documented
elevation in lipid peroxidation with PUFA dietary supple-
mentation as illustrated by decreased GSH and elevated
urinary isoprostanes. Presence of diminished quantities of
GSH implies consumption via oxidant injury. Elevation in
urinary isoprostanes is consistent with lipid peroxidation,
as these compounds result from the reaction of arachidonic
acid contained within cellular membranes and reactive
oxidantspecies[6].However,thelevelsofisoprostanesfound
in this paper have not been correlated with histologic or
metabolic disturbance. In addition, corresponding markers
ofinﬂammation(CRP)werenotelevated.Inthispopulation,
we documented a diminished antioxidant status. Despite
this alteration in baseline antioxidant status, no change in
markers of inﬂammation was anticipated in the absence of
systemic insult, such as that due to disease or trauma. Fur-
thermore, 21 days of supplementation may not be suﬃcient
to detect this change. In a study of normal dogs undergoing a
combination of EPA and DHA dietary supplementation over
12 weeks, decreased inﬂammatory cytokine activity was doc-
umented [7]. Further support can be found in a recent study
where combined EPA and DHA dietary supplementation
over 56 days also augmented plasma PUFA concentrations
butdecreasedconcentrationofsynovialdegradativeenzymes
in dogs with inﬂammatory joint disease [8]. Although the
mechanism of action of these supplements on joint health
was unknown, the authors theorized that the beneﬁcial
eﬀects seen with supplementation were due to diminished
release of inﬂammatory cytokines
Study limitations are related to the population studied.
Dogswereofvariousbreedsandagesandunderwentunspec-
iﬁed management routines. Diet was also not controlled.
Dietary requirement for vitamin E is closely related to PUFA
consumption as sequestration of Vitamin E allows main-
tenance of antioxidant stability, with the ratio of Vitamin
E/PUFA recommended in human diets is 0.4mg/gram [9].
As this study incorporated healthy dogs on various diets,
the vitamin E to PUFA ratio was not evaluated. However,
the population of dogs evaluated was designed to represent
a subpopulation of typical healthy dogs maintained in the
home. This population is the target for evaluation of dietary
supplements given in addition to a dog’s routine diet.
Dietarysupplementsareoftengivenwithoutregardforother
dietary intake and the eﬀect of supplementation under these
conditions was the primary interest. To minimize variability
and ensure appropriate comparisons, dogs acted as their
own control with plasma, serum, and urine measurements
performed prior to and following dietary supplementation.
Due to conﬂicting reports in eﬃcacy of PUFA dietary
supplementation in dogs, this area of nutrition research
requires further study. Healthy dogs supplemented with CLA
in this report experienced the highest increase in markers
of lipid peroxidation and this increase was dose dependent.
Caution should be exercised when supplementing commer-
cial canine diets with PUFAs as some types may increase the
risk of lipid peroxidation and oxidant injury. Owners should
be advised prior to empirical supplementation of fatty acids.
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